Louisiana · 2026 Regular Session · Resolution

HR 174: DRUGS/TESTING: Requests the state surgeon general and the Louisiana Department of Health to assess the feasibility of advancing fenbendazole or similar treatments for potential human use in cancer treatment and to provide guidance on engaging federal authorities for expedited evaluation while protecting public health

In committee Last action May 21, 2026: Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.

Plain-language summary

HR 174 is a resolution introduced in the Louisiana House on April 20, 2026. According to its official title, it concerns: DRUGS/TESTING: Requests the state surgeon general and the Louisiana Department of Health to assess the feasibility of advancing fenbendazole or similar treatments for potential human use in cancer treatment and to provide guidance on engaging federal authorities for expedited evaluation while protecting public health. Primary sponsor: Chuck Owen (Republican). It lists 8 additional sponsors. Most recent recorded action (May 21, 2026): Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.

Sponsors

Primary sponsor: Chuck Owen (Republican). 8 co-sponsors.